Latest Breaking News On - Ma203cd8 - Page 1 : comparemela.com

IMA203CD8 is a 2nd-generation product candidate co-expressing Immatics' proprietary CD8aß co-receptor engaging functional CD4 and CD8 T cells directed against PRAME Preclinical data with IMA203CD8

United statesTwitterand linkedinEva mulderCedrik brittenAnja heuerImmatic actengineTexasand tuebingenCorporate communicationsTrophic communicationsChief medical officerAll immaticStem cell therapeutics research laboratoryAdoptive cell therapiesLooking statementsInvestor relations